Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cosmos Health Inc (COSM)

Cosmos Health Inc (COSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,442
  • Shares Outstanding, K 16,933
  • Annual Sales, $ 50,350 K
  • Annual Income, $ -13,830 K
  • 60-Month Beta 5.84
  • Price/Sales 0.13
  • Price/Cash Flow N/A
  • Price/Book 0.20
Trade COSM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.11
  • Most Recent Earnings $-0.09 on 11/21/23
  • Latest Earnings Date 05/21/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 257.27% ( -829.72%)
  • Historical Volatility 108.50%
  • IV Percentile 54%
  • IV Rank 11.92%
  • IV High 1,368.20% on 02/07/24
  • IV Low 106.87% on 11/20/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 255
  • Open Int (30-Day) 409

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -250.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4677 +45.39%
on 04/22/24
0.7300 -6.85%
on 04/11/24
-0.0150 (-2.16%)
since 04/03/24
3-Month
0.4677 +45.39%
on 04/22/24
1.1800 -42.37%
on 02/05/24
-0.3950 (-36.74%)
since 02/02/24
52-Week
0.4677 +45.39%
on 04/22/24
4.0000 -83.00%
on 06/06/23
-2.5200 (-78.75%)
since 05/03/23

Most Recent Stories

More News
MarketBeat: Week in Review 11/28 – 12/02

Investors continue to monitor the Federal Reserve, but the MarketBeat team helps you look past the headlines. Here are the stories moving the market this week

JD : 32.87 (+0.70%)
BBY : 74.47 (+2.80%)
ZM : 61.82 (-1.61%)
OGI : 1.8550 (-1.33%)
COSM : 0.6800 (+0.64%)
AAPL : 183.38 (+5.98%)
SOFI : 6.96 (-0.43%)
NIO : 5.57 (-0.36%)
XPEV : 9.06 (-3.62%)
QSR : 75.83 (+2.18%)
DPZ : 514.33 (+0.32%)
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk

Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment

COSM : 0.6800 (+0.64%)
GME : 16.47 (+29.08%)
AMC : 3.30 (+5.43%)
PFE : 27.81 (+0.40%)
GSK : 43.50 (+0.35%)
AZN : 76.35 (+0.73%)
Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection,...

COSM : 0.6800 (+0.64%)
VRAX : 0.6139 (+0.64%)
Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board

CHICAGO, IL / ACCESSWIRE / July 22 , 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded...

APHA : 15.38 (-0.45%)
COSM : 0.6800 (+0.64%)
Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands

CHICAGO, IL / ACCESSWIRE / July 20, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded...

COSM : 0.6800 (+0.64%)
Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association

Products will be listed on PAGB's OTC Directory online, a go-to resource for healthcare professionals

COSM : 0.6800 (+0.64%)
Cosmos Holdings Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board

CHICAGO, IL / ACCESSWIRE / July 8, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded...

COSM : 0.6800 (+0.64%)
Cosmos Holdings to Acquire LIFE NLB Portfolio of Bone Health Products that Target the Gastrointestinal Microbiome

Acquisition will include all launched and under development bone health products

COSM : 0.6800 (+0.64%)
Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders

CHICAGO, IL / ACCESSWIRE / June 30, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded...

COSM : 0.6800 (+0.64%)
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States

First commercial launch of the Company's nutraceutical products in the U.S. follows successful launches on Amazon in other key markets

COSM : 0.6800 (+0.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cosmos Health is a healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices. Cosmos Health, formerly known as Cosmos Holdings Inc., is based in CHICAGO, IL.

See More

Key Turning Points

3rd Resistance Point 0.7300
2nd Resistance Point 0.7150
1st Resistance Point 0.6975
Last Price 0.6800
1st Support Level 0.6650
2nd Support Level 0.6500
3rd Support Level 0.6325

See More

52-Week High 4.0000
Fibonacci 61.8% 2.6507
Fibonacci 50% 2.2339
Fibonacci 38.2% 1.8170
Last Price 0.6800
52-Week Low 0.4677

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar